Cholera - Pipeline Review, H1 2019 Featuring Akthelia Pharmaceuticals, Beijing Minhai Biotechnology Co, and Napo Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 16, 2019--The "Cholera - Pipeline Review, H1 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
